Cargando…

Engineered nanoparticles induce cell apoptosis: potential for cancer therapy

Engineered nanoparticles (ENPs) have been widely applied in industry, commodities, biology and medicine recently. The potential for many related threats to human health has been highlighted. ENPs with their sizes no larger than 100 nm are able to enter the human body and accumulate in organs such as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Dan-Dan, Yang, Wan-Xi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130051/ https://www.ncbi.nlm.nih.gov/pubmed/27056889 http://dx.doi.org/10.18632/oncotarget.8553

Ejemplares similares

Targeting Engineered Nanoparticles for Breast Cancer Therapy
por: Ganesan, Kumar, et al.
Publicado: (2021)

Engineered extracellular vesicles: potentials in cancer combination therapy
por: Chen, Jiangbin, et al.
Publicado: (2022)

Role of Autophagy in Zinc Oxide Nanoparticles-Induced Apoptosis of Mouse LEYDIG Cells
por: Shen, Jingcao, et al.
Publicado: (2019)

The neurotoxicity induced by engineered nanomaterials
por: Ge, Dan, et al.
Publicado: (2019)

Engineered Gold Nanoparticles and Plant Adaptation Potential
por: Siddiqi, Khwaja Salahuddin, et al.
Publicado: (2016)

Zinc oxide nanoparticles induce apoptosis and autophagy in human ovarian cancer cells
por: Bai, Ding-Ping, et al.
Publicado: (2017)

Effect of sun ginseng potentiation on epirubicin and paclitaxel-induced apoptosis in human cervical cancer cells
por: Lin, Yingjia, et al.
Publicado: (2014)

Translational nanoparticle engineering for cancer vaccines
por: Grippin, Adam J., et al.
Publicado: (2017)

Behavior and Potential Impacts of Metal-Based Engineered Nanoparticles in Aquatic Environments
por: Peng, Cheng, et al.
Publicado: (2017)

Acceptor Engineering Produces Ultrafast Nonradiative Decay in NIR-II Aza-BODIPY Nanoparticles for Efficient Osteosarcoma Photothermal Therapy via Concurrent Apoptosis and Pyroptosis
por: Shi, Zhenxiong, et al.
Publicado: (2023)

Migratory Engineering of T Cells for Cancer Therapy
por: Michaelides, Stefanos, et al.
Publicado: (2022)

Lectins with Potential for Anti-Cancer Therapy
por: Yau, Tammy, et al.
Publicado: (2015)

Engineered extracellular vesicles-like biomimetic nanoparticles as an emerging platform for targeted cancer therapy
por: Liu, Xinyi, et al.
Publicado: (2023)

Therapeutic potential of CAR-T cell-derived exosomes: a cell-free modality for targeted cancer therapy
por: Tang, Xiang-Jun, et al.
Publicado: (2015)

Biomimetic and Materials-Potentiated Cell Engineering for Cancer Immunotherapy
por: Zhang, Tingting, et al.
Publicado: (2022)

Macrophage-evading and tumor-specific apoptosis inducing nanoparticles for targeted cancer therapy
por: Liu, Zimo, et al.
Publicado: (2023)

Apoptosis-Inducing TNF Superfamily Ligands for Cancer Therapy
por: Diaz Arguello, Olivia A., et al.
Publicado: (2021)

Combination of salinomycin and silver nanoparticles enhances apoptosis and autophagy in human ovarian cancer cells: an effective anticancer therapy
por: Zhang, Xi-Feng, et al.
Publicado: (2016)

Engineered Cell Membrane‐Derived Nanoparticles in Immune Modulation
por: Yang, Yixiao, et al.
Publicado: (2021)

Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy
por: Jia, Ming, et al.
Publicado: (2021)

Genetically engineered T cells for cancer immunotherapy
por: Li, Dan, et al.
Publicado: (2019)

Therapeutic Inducers of Apoptosis in Ovarian Cancer
por: Binju, Mudra, et al.
Publicado: (2019)

Titanium dioxide nanoparticles perturb the blood-testis barrier via disruption of actin-based cell adhesive function
por: Ni, Dong-Qi, et al.
Publicado: (2021)

Engineered nanoparticles interacting with cells: size matters
por: Shang, Li, et al.
Publicado: (2014)

Genetically Engineered Bacterial Protein Nanoparticles for Targeted Cancer Therapy
por: Yang, Haiyan, et al.
Publicado: (2021)

Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy
por: Zhou, Yang, et al.
Publicado: (2022)

Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach
por: Chen, Lian, et al.
Publicado: (2015)

New opportunities for RGD-engineered metal nanoparticles in cancer
por: Qin, Wei, et al.
Publicado: (2023)

Chimeric antigen receptor engineered natural killer cells for cancer therapy
por: Zhang, Yalan, et al.
Publicado: (2023)

Engineering Nanoparticles to Reprogram the Tumor Immune Microenvironment for Improved Cancer Immunotherapy
por: Saeed, Madiha, et al.
Publicado: (2019)

Metal Nanoparticles for Photodynamic Therapy: A Potential Treatment for Breast Cancer
por: Shang, Liang, et al.
Publicado: (2021)

Progress in the Surface Functionalization of Selenium Nanoparticles and Their Potential Application in Cancer Therapy
por: Chen, Wanwen, et al.
Publicado: (2022)

Green Synthesis of Metallic Nanoparticles and Their Potential Applications to Treat Cancer
por: Zhang, Dan, et al.
Publicado: (2020)

Tight junction between endothelial cells: the interaction between nanoparticles and blood vessels
por: Zhang, Yue, et al.
Publicado: (2016)

Engineered human pluripotent stem cell-derived natural killer cells: the next frontier for cancer immunotherapy
por: Zhu, Huang, et al.
Publicado: (2019)

Engineering Exosomes for Cancer Therapy
por: Gilligan, Katie E., et al.
Publicado: (2017)

A Potent Lead Induces Apoptosis in Pancreatic Cancer Cells
por: Liu, Zuojia, et al.
Publicado: (2012)

Artesunate induces apoptosis and autophagy in HCT116 colon cancer cells, and autophagy inhibition enhances the artesunate-induced apoptosis
por: Jiang, Feng, et al.
Publicado: (2018)

Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy
por: Gao, Shan, et al.
Publicado: (2019)

Engineering Gold Nanostructures for Cancer Treatment: Spherical Nanoparticles, Nanorods, and Atomically Precise Nanoclusters
por: He, Wei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e7akc5rcm3avlqbv8kfqg1uh1e